Atika Capital Management, LLC is an SEC-registered investment adviser based in New York, NY that reports managing 3 hedge funds on Form ADV. It reports $887.3 million in regulatory assets under management. Its private funds, of all types, hold $887.3 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +34.5% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +72.5% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $887.3 millionForm ADV Item 5.F
- Gross assets of private funds
- $887.3 millionAll private fund types, Form ADV
- Hedge funds managed
- 33 private funds in total
- Employees
- 9Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 167227
- Latest Form ADV
- 03/26/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +25.8% | +14.8% |
| Q1 2026 | +7.0% | -4.6% |
| Q4 2025 | +1.9% | +2.4% |
| Q3 2025 | +6.9% | +7.8% |
| Q2 2025 | +24.3% | +10.4% |
| Q1 2025 | -9.4% | -4.5% |
| Q4 2024 | -2.1% | +2.1% |
| Q3 2024 | +6.8% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
The 50 largest of 70 share positions ($1,022,512,714) reported by Atika Capital Management LLC on Form 13F for the quarter ended Sep 30, 2026, filed Nov 13, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Vertiv Holdings Co15.72%
- Advanced Micro Devices Inc7.99%
- Seagate Technology Hldngs PL7.11%
- Eli Lilly & Co5.33%
- Intel Corp4.35%
- Guardant Health Inc3.54%
- Intuitive Surgical Inc3.47%
- Sitime Corp3.19%
- Echostar Corp3.00%
- Amazon Com Inc2.07%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Vertiv Holdings Co | $160,736,590 | 15.72% | 666,100 | Unchanged |
| Advanced Micro Devices Inc | $81,731,137 | 7.99% | 133,600 | +39.90% |
| Seagate Technology Hldngs PL | $72,675,780 | 7.11% | 78,795 | -1.34% |
| Eli Lilly & Co | $54,498,468 | 5.33% | 47,100 | +14.60% |
| Intel Corp | $44,438,571 | 4.35% | 369,613 | +40.00% |
| Guardant Health Inc | $36,207,080 | 3.54% | 203,000 | +12.15% |
| Intuitive Surgical Inc | $35,464,642 | 3.47% | 87,216 | +52.43% |
| Sitime Corp | $32,601,500 | 3.19% | 50,000 | +233.33% |
| Echostar Corp | $30,703,394 | 3.00% | 343,400 | +3.62% |
| Amazon Com Inc | $21,177,750 | 2.07% | 85,000 | +93.18% |
| Ciena Corp | $19,007,427 | 1.86% | 54,026 | +10.78% |
| Twist Bioscience Corp | $17,198,361 | 1.68% | 89,000 | +23.61% |
| Meta Platforms Inc | $16,316,551 | 1.60% | 22,500 | New |
| BBB Foods Inc | $14,949,761 | 1.46% | 284,000 | +13.60% |
| 10X Genomics Inc | $14,457,601 | 1.41% | 160,000 | New |
| Shopify Inc | $14,014,350 | 1.37% | 94,500 | New |
| Five Below Inc | $13,832,910 | 1.35% | 63,000 | +57.50% |
| Revolution Medicines Inc | $12,931,380 | 1.26% | 63,000 | -28.41% |
| Taiwan Semiconductor Manufac | $12,773,320 | 1.25% | 28,000 | New |
| Netflix Inc. | $12,524,400 | 1.22% | 180,000 | Unchanged |
| Charles Riv Labs Intl Inc | $12,390,420 | 1.21% | 42,000 | +10.53% |
| Robinhood Mkts Inc | $12,150,001 | 1.19% | 108,000 | New |
| Teva Pharmaceutical Inds LTD | $11,484,000 | 1.12% | 290,000 | New |
| Sharkninja Inc | $10,807,199 | 1.06% | 60,000 | -31.82% |
| Merck & Co Inc | $10,462,321 | 1.02% | 72,000 | New |
| Cloudflare Inc | $9,723,840 | 0.95% | 28,000 | New |
| Appfolio Inc | $9,524,699 | 0.93% | 47,500 | Unchanged |
| United STS Oil FD LP | $9,030,920 | 0.88% | 62,000 | New |
| Mastec Inc | $8,972,040 | 0.88% | 42,000 | -21.13% |
| Doordash Inc | $8,810,400 | 0.86% | 48,000 | New |
| Bloom Energy Corp | $8,724,870 | 0.85% | 31,500 | New |
| Veradermics Inc | $8,546,715 | 0.84% | 70,500 | +487.50% |
| Dianthus Therapeutics Inc | $8,540,850 | 0.84% | 97,000 | -41.21% |
| Roivant Sciences LTD | $8,228,250 | 0.80% | 225,000 | +3.69% |
| Rocket Lab Corp | $8,222,240 | 0.80% | 118,000 | -30.18% |
| Vishay Precision Group Inc | $8,219,619 | 0.80% | 113,000 | -4.24% |
| Schrodinger Inc | $7,684,874 | 0.75% | 247,500 | New |
| Viking Therapeutics Inc | $7,498,000 | 0.73% | 230,000 | New |
| BWX Technologies Inc | $7,398,000 | 0.72% | 54,000 | Unchanged |
| Ferguson Enterprises Inc | $6,522,767 | 0.64% | 29,300 | Unchanged |
| United Therapeutics Corp Del | $6,502,680 | 0.64% | 12,000 | New |
| Gitlab Inc | $6,378,750 | 0.62% | 135,000 | New |
| Box Inc | $6,361,200 | 0.62% | 190,000 | New |
| Listed FDS TR | $6,308,720 | 0.62% | 88,000 | New |
| Protagonist Therapeutics Inc | $6,199,160 | 0.61% | 44,000 | -29.15% |
| Frontier Group Hldgs Inc | $6,089,400 | 0.60% | 1,020,000 | New |
| Cogent Biosciences Inc | $5,507,440 | 0.54% | 172,000 | -36.76% |
| Jfrog LTD | $5,337,200 | 0.52% | 55,000 | New |
| Snowflake Inc | $5,297,137 | 0.52% | 15,600 | New |
| Kymera Therapeutics Inc | $5,030,550 | 0.49% | 45,000 | -56.73% |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 34 new positions, 26 sold out, 16 increased, 13 reduced and 7 unchanged.
Number of positions (a count, not dollars)
- New positions34
- Increased16
- Unchanged7
- Reduced13
- Sold out26
New positions
| Stock | Value | Shares |
|---|---|---|
| Meta Platforms Inc | $16,316,551 | 22,500 |
| 10X Genomics Inc | $14,457,601 | 160,000 |
| Shopify Inc | $14,014,350 | 94,500 |
| Taiwan Semiconductor Manufac | $12,773,320 | 28,000 |
| Robinhood Mkts Inc | $12,150,001 | 108,000 |
| Teva Pharmaceutical Inds LTD | $11,484,000 | 290,000 |
| Merck & Co Inc | $10,462,321 | 72,000 |
| Cloudflare Inc | $9,723,840 | 28,000 |
| United STS Oil FD LP | $9,030,920 | 62,000 |
| Doordash Inc | $8,810,400 | 48,000 |
| Bloom Energy Corp | $8,724,870 | 31,500 |
| Schrodinger Inc | $7,684,874 | 247,500 |
| Viking Therapeutics Inc | $7,498,000 | 230,000 |
| United Therapeutics Corp Del | $6,502,680 | 12,000 |
| Gitlab Inc | $6,378,750 | 135,000 |
| Box Inc | $6,361,200 | 190,000 |
| Listed FDS TR | $6,308,720 | 88,000 |
| Frontier Group Hldgs Inc | $6,089,400 | 1,020,000 |
| Jfrog LTD | $5,337,200 | 55,000 |
| Snowflake Inc | $5,297,137 | 15,600 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Marvell Technology Inc | $17,277,620 | 58,000 |
| Western Digital Corp | $16,911,389 | 26,477 |
| Ascendis Pharma A/s | $16,269,920 | 61,000 |
| Axsome Therapeutics Inc. | $15,420,511 | 63,000 |
| Teva Pharmaceutical Inds LTD | $14,907,200 | 440,000 |
| Axogen Inc | $10,207,991 | 221,000 |
| Nokia Corp | $9,960,000 | 750,000 |
| Oruka Therapeutics Inc | $9,517,000 | 100,000 |
| TTM Technologies Inc | $9,351,000 | 50,000 |
| Acm Resh Inc | $7,994,069 | 63,000 |
| Mercadolibre Inc | $7,655,229 | 4,510 |
| Reddit Inc | $7,463,940 | 43,000 |
| Semtech Corp | $7,445,100 | 46,000 |
| Definium Therapeutics Inc | $5,738,880 | 122,000 |
| Immunome Inc | $5,570,851 | 262,900 |
| Hut 8 Corp | $5,137,302 | 44,500 |
| Warby Parker Inc | $4,551,000 | 150,000 |
| Nlight Inc | $3,829,100 | 55,000 |
| Abivax SA | $3,598,020 | 27,000 |
| Alkermes PLC | $2,911,643 | 55,571 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Advanced Micro Devices Inc | +38,100 | +39.90% | $81,731,137 | 133,600 |
| Sitime Corp | +35,000 | +233.33% | $32,601,500 | 50,000 |
| Intel Corp | +105,613 | +40.00% | $44,438,571 | 369,613 |
| Intuitive Surgical Inc | +30,000 | +52.43% | $35,464,642 | 87,216 |
| Amazon Com Inc | +41,000 | +93.18% | $21,177,750 | 85,000 |
| Veradermics Inc | +58,500 | +487.50% | $8,546,715 | 70,500 |
| Eli Lilly & Co | +6,000 | +14.60% | $54,498,468 | 47,100 |
| Five Below Inc | +23,000 | +57.50% | $13,832,910 | 63,000 |
| Guardant Health Inc | +22,000 | +12.15% | $36,207,080 | 203,000 |
| Twist Bioscience Corp | +17,000 | +23.61% | $17,198,361 | 89,000 |
| Ciena Corp | +5,258 | +10.78% | $19,007,427 | 54,026 |
| BBB Foods Inc | +34,000 | +13.60% | $14,949,761 | 284,000 |
| Charles Riv Labs Intl Inc | +4,000 | +10.53% | $12,390,420 | 42,000 |
| Echostar Corp | +12,000 | +3.62% | $30,703,394 | 343,400 |
| Praxis Precision Medicines I | +2,000 | +15.50% | $4,339,327 | 14,900 |
| Roivant Sciences LTD | +8,000 | +3.69% | $8,228,250 | 225,000 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Kymera Therapeutics Inc | -59,000 | -56.73% | $5,030,550 | 45,000 |
| Dianthus Therapeutics Inc | -68,000 | -41.21% | $8,540,850 | 97,000 |
| Revolution Medicines Inc | -25,000 | -28.41% | $12,931,380 | 63,000 |
| Sharkninja Inc | -28,000 | -31.82% | $10,807,199 | 60,000 |
| Curtiss Wright Corp | -8,000 | -50.00% | $4,350,560 | 8,000 |
| The Realreal Inc | -407,000 | -43.30% | $4,711,720 | 533,000 |
| Rocket Lab Corp | -51,000 | -30.18% | $8,222,240 | 118,000 |
| Cogent Biosciences Inc | -100,000 | -36.76% | $5,507,440 | 172,000 |
| Protagonist Therapeutics Inc | -18,100 | -29.15% | $6,199,160 | 44,000 |
| Mastec Inc | -11,250 | -21.13% | $8,972,040 | 42,000 |
| Seagate Technology Hldngs PL | -1,070 | -1.34% | $72,675,780 | 78,795 |
| Krystal Biotech Inc | -2,000 | -33.33% | $1,330,240 | 4,000 |
| Vishay Precision Group Inc | -5,000 | -4.24% | $8,219,619 | 113,000 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| JATT II Acquisition Corp. | 13G | 5.1% | 400,000 | Aug 14, 2026 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Aug 14, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Hedge funds filing Form D (2)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (3)
As reported in the adviser's Form ADV filed Mar 25, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures